These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10870628)

  • 21. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.
    Goossens H; Ferech M; Coenen S; Stephens P;
    Clin Infect Dis; 2007 Apr; 44(8):1091-5. PubMed ID: 17366456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-related mortality in Canada (1984-1994).
    Mittmann N; Liu BA; Iskedjian M; Bradley CA; Pless R; Shear NH; Einarson TR
    Pharmacoepidemiol Drug Saf; 1997 May; 6(3):157-68. PubMed ID: 15073784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The market of synonymous preparations in Denmark 1985-1990. A comparison of prices and quantities on the market].
    Nissen A
    Ugeskr Laeger; 1991 Dec; 153(50):3558-62. PubMed ID: 1776198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Critical analysis of drugs in 1989].
    Vrhovac B; Vrhovac R
    Lijec Vjesn; 1990; 112(5-6):131-7. PubMed ID: 2233108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.
    Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):423-7. PubMed ID: 16735418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A classification of drug substances according to their mechanism of action.
    Imming P; Buss T; Dailey LA; Meyer A; Morck H; Ramadan M; Rogosch T
    Pharmazie; 2004 Aug; 59(8):579-89. PubMed ID: 15378843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New classification of drugs. The Medical list and the Drug catalogue are introduced in Anatomical--Therapeutic--Chemical classification code (ACT-code) in 1981].
    Hvidberg E; Andersen AH
    Ugeskr Laeger; 1980 Feb; 142(6):396-7. PubMed ID: 7368387
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization and classification of adverse drug interactions.
    Takarabe M; Shigemizu D; Kotera M; Goto S; Kanehisa M
    Genome Inform; 2010 Jan; 22():167-75. PubMed ID: 20238427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering drugs: use and expenditure in Portugal (1995-2004).
    Teixeira IJ; Escoval A; Schiappa M
    Rev Port Cardiol; 2007 May; 26(5):475-93. PubMed ID: 17691275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of prescription in discharge reports at a university hospital].
    Matoses Chirivella MC; Nájera Pérez MD; León Villar J; Iranzo Fernández MD; Plaza Aniorte J; Munilla Das A; Romero Crespo I; Ventura López M
    Farm Hosp; 2004; 28(3):180-7. PubMed ID: 15222871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care].
    Pittrow D; Krappweis J; Kirch W
    Dtsch Med Wochenschr; 2002 Sep; 127(39):1995-2000. PubMed ID: 12324879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of utilization of cardiovascular drugs in the Czech Republic and in Wales].
    Górecká K; Vlcek J; Walker R
    Vnitr Lek; 2003 Aug; 49(8):592-7. PubMed ID: 14518081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of follow-on drugs and indications on the WHO Essential Drug List.
    Cohen J; Cabanilla L; Sosnov J
    J Clin Pharm Ther; 2006 Dec; 31(6):585-92. PubMed ID: 17176363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A; Lindquist M; Orre R; Edwards IR; Meyboom RH
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of drug utilization from positive lists].
    Perlík F; Kubica Z; Stika L
    Cas Lek Cesk; 1999 Jan; 138(2):56-8. PubMed ID: 10376405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Croatian pharmaceutical sector reform project: rational drug use.
    Harvey K; Kalanj K; Stevanović R
    Croat Med J; 2004 Oct; 45(5):611-9. PubMed ID: 15495290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic drugs in Bulgaria-frequency and risk of adverse drug reactions.
    Dimitrova Z; Doma A; Petkova V; Getov I; Verkkunen E
    Boll Chim Farm; 2002; 141(1):75-9. PubMed ID: 12064062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.